vs
RADIANT LOGISTICS, INC（RLGT）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
RADIANT LOGISTICS, INC的季度营收约是再鼎医药的1.8倍（$232.1M vs $127.1M），再鼎医药同比增速更快（17.1% vs -12.3%），RADIANT LOGISTICS, INC自由现金流更多（$11.6M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 12.1%）
Radiant Logistics, Inc.是一家知名第三方物流服务商，提供端到端供应链解决方案、国内外货运代理、仓储及末端配送服务，核心市场覆盖北美，客户涵盖零售、制造、电商、工业等多个领域，助力企业优化物流流程、降低运营成本。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
RLGT vs ZLAB — 直观对比
营收规模更大
RLGT
是对方的1.8倍
$127.1M
营收增速更快
ZLAB
高出29.4%
-12.3%
自由现金流更多
RLGT
多$38.3M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
12.1%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $232.1M | $127.1M |
| 净利润 | $5.3M | — |
| 毛利率 | — | 51.0% |
| 营业利润率 | 3.2% | -54.6% |
| 净利率 | 2.3% | — |
| 营收同比 | -12.3% | 17.1% |
| 净利润同比 | -18.0% | — |
| 每股收益（稀释后） | $0.11 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RLGTZLAB
| Q4 25 | $232.1M | $127.1M | ||
| Q3 25 | $226.7M | $115.4M | ||
| Q2 25 | $220.6M | $109.1M | ||
| Q1 25 | $214.0M | $105.7M | ||
| Q4 24 | $264.5M | $108.5M | ||
| Q3 24 | $203.6M | $101.8M | ||
| Q2 24 | $206.0M | $100.1M | ||
| Q1 24 | $184.6M | $87.1M |
净利润RLGTZLAB
| Q4 25 | $5.3M | — | ||
| Q3 25 | $1.3M | $-36.0M | ||
| Q2 25 | $4.9M | $-40.7M | ||
| Q1 25 | $2.5M | $-48.4M | ||
| Q4 24 | $6.5M | — | ||
| Q3 24 | $3.4M | $-41.7M | ||
| Q2 24 | $4.8M | $-80.3M | ||
| Q1 24 | $-703.0K | $-53.5M |
毛利率RLGTZLAB
| Q4 25 | — | 51.0% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 60.6% | ||
| Q1 25 | — | 63.6% | ||
| Q4 24 | — | 61.5% | ||
| Q3 24 | — | 64.1% | ||
| Q2 24 | — | 64.9% | ||
| Q1 24 | — | 61.4% |
营业利润率RLGTZLAB
| Q4 25 | 3.2% | -54.6% | ||
| Q3 25 | 0.9% | -42.3% | ||
| Q2 25 | 2.4% | -50.3% | ||
| Q1 25 | 1.6% | -53.3% | ||
| Q4 24 | 3.3% | -62.6% | ||
| Q3 24 | 1.9% | -66.6% | ||
| Q2 24 | 2.4% | -76.0% | ||
| Q1 24 | -0.5% | -80.7% |
净利率RLGTZLAB
| Q4 25 | 2.3% | — | ||
| Q3 25 | 0.6% | -31.2% | ||
| Q2 25 | 2.2% | -37.3% | ||
| Q1 25 | 1.2% | -45.8% | ||
| Q4 24 | 2.4% | — | ||
| Q3 24 | 1.7% | -40.9% | ||
| Q2 24 | 2.3% | -80.2% | ||
| Q1 24 | -0.4% | -61.4% |
每股收益（稀释后）RLGTZLAB
| Q4 25 | $0.11 | $-0.05 | ||
| Q3 25 | $0.03 | $-0.03 | ||
| Q2 25 | $0.10 | $-0.04 | ||
| Q1 25 | $0.05 | $-0.04 | ||
| Q4 24 | $0.13 | $-0.09 | ||
| Q3 24 | $0.07 | $-0.04 | ||
| Q2 24 | $0.11 | $-0.08 | ||
| Q1 24 | $-0.02 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $31.9M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $229.8M | $715.5M |
| 总资产 | $439.4M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资RLGTZLAB
| Q4 25 | $31.9M | $689.6M | ||
| Q3 25 | $28.1M | $717.2M | ||
| Q2 25 | $22.9M | $732.2M | ||
| Q1 25 | $19.0M | $757.3M | ||
| Q4 24 | $19.9M | $779.7M | ||
| Q3 24 | $10.4M | $616.1M | ||
| Q2 24 | $24.9M | $630.0M | ||
| Q1 24 | $31.2M | $650.8M |
股东权益RLGTZLAB
| Q4 25 | $229.8M | $715.5M | ||
| Q3 25 | $225.7M | $759.9M | ||
| Q2 25 | $226.0M | $791.7M | ||
| Q1 25 | $218.2M | $810.8M | ||
| Q4 24 | $214.4M | $840.9M | ||
| Q3 24 | $212.4M | $667.7M | ||
| Q2 24 | $209.4M | $704.2M | ||
| Q1 24 | $206.0M | $762.2M |
总资产RLGTZLAB
| Q4 25 | $439.4M | $1.2B | ||
| Q3 25 | $445.3M | $1.2B | ||
| Q2 25 | $426.8M | $1.2B | ||
| Q1 25 | $414.5M | $1.2B | ||
| Q4 24 | $386.8M | $1.2B | ||
| Q3 24 | $375.3M | $985.3M | ||
| Q2 24 | $371.2M | $987.4M | ||
| Q1 24 | $364.0M | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.4M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $11.6M | $-26.7M |
| 自由现金流率自由现金流/营收 | 5.0% | -21.0% |
| 资本支出强度资本支出/营收 | 0.3% | 0.5% |
| 现金转化率经营现金流/净利润 | 2.33× | — |
| 过去12个月自由现金流最近4个季度 | $8.5M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流RLGTZLAB
| Q4 25 | $12.4M | $-26.0M | ||
| Q3 25 | $2.5M | $-32.0M | ||
| Q2 25 | $3.1M | $-31.0M | ||
| Q1 25 | $-5.7M | $-61.7M | ||
| Q4 24 | $15.7M | $-55.8M | ||
| Q3 24 | $205.0K | $-26.8M | ||
| Q2 24 | $1.3M | $-42.2M | ||
| Q1 24 | $3.9M | $-90.1M |
自由现金流RLGTZLAB
| Q4 25 | $11.6M | $-26.7M | ||
| Q3 25 | $977.0K | $-35.0M | ||
| Q2 25 | $2.2M | $-33.9M | ||
| Q1 25 | $-6.4M | $-63.2M | ||
| Q4 24 | $14.1M | $-58.4M | ||
| Q3 24 | $-1.9M | $-28.2M | ||
| Q2 24 | $-185.0K | $-42.9M | ||
| Q1 24 | $1.8M | $-91.1M |
自由现金流率RLGTZLAB
| Q4 25 | 5.0% | -21.0% | ||
| Q3 25 | 0.4% | -30.4% | ||
| Q2 25 | 1.0% | -31.1% | ||
| Q1 25 | -3.0% | -59.9% | ||
| Q4 24 | 5.3% | -53.8% | ||
| Q3 24 | -0.9% | -27.7% | ||
| Q2 24 | -0.1% | -42.9% | ||
| Q1 24 | 1.0% | -104.5% |
资本支出强度RLGTZLAB
| Q4 25 | 0.3% | 0.5% | ||
| Q3 25 | 0.7% | 2.6% | ||
| Q2 25 | 0.4% | 2.6% | ||
| Q1 25 | 0.3% | 1.5% | ||
| Q4 24 | 0.6% | 2.4% | ||
| Q3 24 | 1.0% | 1.3% | ||
| Q2 24 | 0.7% | 0.7% | ||
| Q1 24 | 1.2% | 1.1% |
现金转化率RLGTZLAB
| Q4 25 | 2.33× | — | ||
| Q3 25 | 1.90× | — | ||
| Q2 25 | 0.63× | — | ||
| Q1 25 | -2.26× | — | ||
| Q4 24 | 2.43× | — | ||
| Q3 24 | 0.06× | — | ||
| Q2 24 | 0.26× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RLGT
| Transferred Over Time | $201.2M | 87% |
| Other | $25.0M | 11% |
| Value Added Services | $4.2M | 2% |
| Transferred At Point In Time | $1.8M | 1% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
